Sequential Blood Purification for Pediatric Fatal Toxic Epidermal Necrolysis: A Case Series
暂无分享,去创建一个
Yiping Zhou | Yucai Zhang | Chunxia Wang | Fei Wang | Jingyi Shi | Y. Shan | H. Miao | G. Ding | T. Sun | Yun Cui
[1] N. Dunbar,et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue , 2019, Journal of clinical apheresis.
[2] Z. Tamaki,et al. Clinical features of Stevens–Johnson syndrome and toxic epidermal necrolysis , 2018, Pediatrics international : official journal of the Japan Pediatric Society.
[3] Qi Guo,et al. Successful treatment of toxic epidermal necrolysis using plasmapheresis: A prospective observational study , 2017, Journal of critical care.
[4] M. Schumacher,et al. Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis , 2017, JAMA dermatology.
[5] Yirong Liu,et al. Continuous venovenous hemofiltration combined with hemoperfusion for toxic epidermal necrolysis: a retrospective cohort study , 2017, The Journal of dermatological treatment.
[6] A. Koyfman,et al. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Pediatric Population: A Review , 2016, Pediatric emergency care.
[7] J. Silverberg,et al. Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults. , 2016, The Journal of investigative dermatology.
[8] P. Dziewulski,et al. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016. , 2016, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[9] J. Kellum,et al. High-volume Hemofiltration in the Intensive Care Unit: A Blood Purification Therapy , 2012, Anesthesiology.
[10] G. Koren,et al. Recurrence and Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children , 2011, Pediatrics.
[11] T. Shiohara,et al. Efficacy of plasmapheresis for the treatment of severe toxic epidermal necrolysis: Is cytokine expression analysis useful in predicting its therapeutic efficacy? , 2011, The Journal of dermatology.
[12] Z. Ikezawa,et al. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis]. , 2009, Arerugi = [Allergy].
[13] A. Flahault,et al. Medications as Risk Factors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children: A Pooled Analysis , 2009, Pediatrics.
[14] H. Zirngibl,et al. Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis , 2000, Intensive Care Medicine.
[15] W. Hohenberger,et al. Selective cytokine release induced by serum and separated plasma from septic patients. , 1996, The European journal of surgery = Acta chirurgica.
[16] B. Rzany,et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. , 1991, Archives of dermatology.
[17] R. Westendorp,et al. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. , 1996, Journal of the American Society of Nephrology : JASN.
[18] R. Stern,et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. , 1993, Archives of dermatology.